About Anokion SA

Anokion, a spin-off from the Ecole Polytechnique Fédérale de Lausanne (EPFL), is focused on applying the company’s antigen-specific immune tolerance technology to reduce the immunogenicity of therapeutic proteins and to treat autoimmune and allergic diseases. As a platform technology, Anokion’s approach to antigen-specific tolerance can be translated to virtually any protein in numerous clinical indications.

website icon
Website
employees icon
Employees
industry icon
Industry
IT Services and IT Consulting
location icon
Headquarter
Ecublens
description icon
Founded
2010

Anokion SA Alternatives

Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics

Frequently Asked Questions about Anokion SA

Who are the decision makers in Anokion SA?

The decision makers in Anokion SA are Jessica Spivey, etc. Click to Find Anokion SA decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more